Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,495,000 | 1,615,000 | 1,368,000 | 1,358,000 | 1,508,000 |
| Cost of Goods | 1,262,000 | 1,337,000 | 1,132,000 | 1,085,000 | 1,222,000 |
| Gross Profit | 233,000 | 278,000 | 236,000 | 273,000 | 286,000 |
| Operating Expenses | 139,000 | 483,000 | 183,000 | 191,000 | 267,000 |
| Operating Income | 94,000 | -205,000 | 53,000 | 82,000 | 19,000 |
| Interest Expense | 68,000 | 67,000 | 66,000 | 67,000 | 68,000 |
| Other Income | 25,000 | 11,000 | 13,000 | 5,000 | 17,000 |
| Pre-tax Income | 51,000 | -261,000 | 0 | 20,000 | -32,000 |
| Income Tax | -9,000 | 119,000 | 4,000 | 16,000 | N/A |
| Net Income Continuous | 60,000 | -380,000 | -4,000 | 4,000 | -32,000 |
| Minority Interests | N/A | 1,000 | N/A | N/A | N/A |
| Net Income | $60,000 | $-381,000 | $-4,000 | $4,000 | $-32,000 |
| EPS Basic Total Ops | 0.40 | -2.54 | -0.03 | 0.04 | -0.22 |
| EPS Basic Continuous Ops | 0.40 | -2.53 | -0.03 | 0.03 | -0.21 |
| EPS Diluted Total Ops | 0.40 | -2.54 | -0.03 | 0.04 | -0.22 |
| EPS Diluted Continuous Ops | 0.40 | -2.53 | -0.03 | 0.03 | -0.21 |
| EPS Diluted Before Non-Recurring Items | 0.20 | 0.58 | 0.13 | 0.11 | 0.40 |
| EBITDA(a) | $176,000 | $-110,000 | $144,000 | $168,000 | $151,000 |